-
[show abstract]
[hide abstract]
ABSTRACT: The occurrence of Langerhans cell histiocytosis (LCH) and malignancy in the same patient is rare. When LCH occurs concomitantly with acute leukemia, distinct temporal patterns often exist; acute myelogenous leukemia (AML) typically succeeds LCH, whereas acute lymphocytic leukemia (ALL) usually precedes it. We report a case of LCH developing in a child while in remission for ALL. Unique features of this case include the disseminated nature of the LCH and the death of the patient from LCH rather than ALL.
Journal of the American Academy of Dermatology 01/2002; 45(6 Suppl):S233-4. · 3.99 Impact Factor
-
S S Raimer
Pediatric Annals 05/2001; 30(4):225-9. · 0.48 Impact Factor
-
Archives of Dermatology 02/2001; 137(1):19-21. · 3.89 Impact Factor
-
Archives of Dermatology 05/2000; 136(4):549, 552. · 3.89 Impact Factor
-
S S Raimer
[show abstract]
[hide abstract]
ABSTRACT: Although atopic dermatitis is a very common inflammatory skin condition in children and results in many pediatric healthcare visits, its exact cause is unknown. No single laboratory test can reliably diagnose atopic dermatitis, but a relatively simple set of diagnostic criteria was recently validated for use by practicing physicians. Because existing remedies for atopic dermatitis do not cure the disorder, a program of disease control and management should be pursued. Patients and their caregivers should be advised that current therapies are primarily preventive and palliative. However, a comprehensive plan that includes routine general skin care, medical management of symptoms, identification and avoidance of aggravating factors (including psychological factors), and attention to quality-of-life issues can reduce the occurrence of skin flares. Successful treatment of acute flare-ups can be achieved with appropriate use of topical corticosteroids, but occasionally children afflicted with severe atopic dermatitis require more intensive therapies (e.g., ultraviolet light exposure systemic corticosteroids, and cyclosporine) that need close physician monitoring. Physicians must remain mindful of the psychological and quality-of-life burdens imposed on children with atopic dermatitis and their families and tailor treatments to the needs of each individual patient.
Clinical Pediatrics 02/2000; 39(1):1-14. · 1.15 Impact Factor
-
S S Raimer
[show abstract]
[hide abstract]
ABSTRACT: Many of the dermatologic conditions for which children seek medical attention are caused by infectious organisms. Several medications have recently become available or are on the horizon for the treatment of pediatric skin infections and infestations. Treatment of tinea capitis with fluconazole, itraconazole, and terbinafine, antibiotic therapy for staphylococcal skin infections, cidofovir for the treatment of verrucae vulgaris and molluscum contagiosum and ivermectin for scabies and head lice are discussed.
Dermatologic Clinics 02/2000; 18(1):73-8, viii. · 2.16 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: Physicians may administer intravenous dyes to patients, most commonly to delineate vascular or urinary anatomy, without an appreciation of the potential hazards associated with these compounds. We report two cases in which skin eruptions followed the intravenous administration of the dyes fluorescein and methylene blue; these eruptions were the same colors as the dyes. In our first patient, urticaria, which was yellowish in color and fluorescent under a Wood's lamp, occurred after the administration of fluorescein. In the second patient, painful blue macules appeared randomly on the forearm within 15 seconds after methylene blue was injected into a free-flowing intravenous cannula on the dorsal aspect of the hand.
Cutis; cutaneous medicine for the practitioner 03/1999; 63(2):103-6. · 0.81 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: First described by Shelley and Wood in 1977, mid-dermal elastolysis (MDE) is a rare acquired disorder in which there is a bandlike absence of elastic tissue limited to the mid-dermis. In their patient, MDE developed in an area previously involved with recurrent episodes of urticaria. We describe a 15-year-old white girl with well-circumscribed, minimally palpable yellow-white plaques and wrinkling diagnosed histologically as MDE in areas clinically diagnosed 5 years previously as granuloma annulare. As in the first described patient, five years elapsed between clearance of the original skin lesions and the clinical appearance of MDE. To our knowledge, we report the first adolescent case of MDE localized to previous sites of lesions clinically consistent with granuloma annulare and propose that MDE represents an abnormal end-stage reaction to multiple processes.
Journal of the American Academy of Dermatology 12/1997; 37(5 Pt 2):870-2. · 3.99 Impact Factor
-
Journal of the American Academy of Dermatology 08/1997; 37(1):127-8. · 3.99 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The clinical and pathologic findings of Kikuchi's histiocytic necrotizing lymphadenitis may mimic those of malignant lymphoma. We describe a 6-year-old boy with generalized lymphadenopathy, spiking fever, chills, myalgias, malaise, and erythematous, crusted papules. Although cutaneous manifestations have been noted in 16% to 40% of patients with histiocytic necrotizing lymphadenitis, only three publications described skin lesions. The skin lesions and affected lymph nodes revealed histiocytic aggregates, atypical lymphoid cells, karyorrhectic debris, and patchy necrosis. Spontaneous resolution occurred in 2 months. Results of serologic studies, Epstein-Barr virus (EBV) latent membrane protein immunoperoxidase staining, EBER-1 RNA in-situ hybridization, and EBV EBNA-1 DNA polymerase chain reaction implicate EBV as the causative agent.
Journal of the American Academy of Dermatology 03/1997; 36(2 Pt 2):342-6. · 3.99 Impact Factor
-
Archives of Dermatology 08/1996; 132(7):822-3, 825-6. · 3.89 Impact Factor
-
Archives of Dermatology 07/1996; 132(6):704-5, 707-8. · 3.89 Impact Factor
-
Archives of Dermatology 03/1995; 131(2):227. · 3.89 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: We describe 5 new cases of striated muscle hamartoma (SMH) and review the 7 cases previously described in the literature. Eleven of the 12 patients had single lesions centrally located on the chin (4), near the ala of the nose (3), on the upper chest (3), and on the upper lip (1). Histologically all of the lesions were characterized by a central core containing bundles and individual fibers of skeletal muscle as well as other mesenchymal elements. The muscle fibers penetrated the dermis among numerous folliculo-sebaceous structures. Of the 12 cases of SMH, 3 had other associated congenital anomalies including a cleft lip in 1 patient and a thyroglossal duct sinus in another with single lesions, and preauricular sinuses, low-set ears and bilateral sclerocorneas in the case of multiple SMH. The relationship of SMH with oculocerebrocutaneous syndrome is discussed, and we conclude that at least some of the skin appendages associated with that syndrome are SMH.
Journal of Cutaneous Pathology 03/1994; 21(1):40-6. · 1.56 Impact Factor
-
S S Raimer
Advances in Dermatology 02/1994; 9:193-203; discussion 204.
-
[show abstract]
[hide abstract]
ABSTRACT: Reviewed herein are the major types of vasculitis affecting children, including Henoch-Schönlein purpura, necrotizing vasculitis of small vessels, Kawasaki's disease, and, less commonly, classic polyarteritis nodosa, Wegener's granulomatosis, Churg Strauss syndrome, and lymphomatoid granulomatosis. The clinical features, diagnosis, treatment, and suspected etiologies and pathogenic mechanisms for each entity are discussed.
Seminars in dermatology 04/1992; 11(1):48-56.
-
[show abstract]
[hide abstract]
ABSTRACT: An unusual case of isolated exophytic elastic tissue nevi in the scrotal region of a 64-year-old man is described. The histological and ultrastructural findings were those of abundant abnormal elastic fibers and increased reticulin in the dermis. This hamartomatous lesion possesses clinical and histological features previously undescribed in connective tissue nevi.
Journal of Cutaneous Pathology 01/1992; 18(6):457-63. · 1.56 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: The glucagonoma syndrome is characterized by elevated serum glucagon, a pancreatic alpha-cell tumor, anemia, hypoaminoacidemia, and necrolytic migratory erythema. Necrolytic migratory erythema may cause marked morbidity and is frequently misdiagnosed. A 42-year-old white woman with a 1 1/2-year history of refractory dermatitis (most severe on the lower extremities) had the glucagonoma syndrome. Her severe morbidity was markedly relieved with the administration of intravenous amino acids. This therapy was successful in controlling the necrolytic migratory erythema through recurrences after somatostatin (SMS 201-995), surgical debulking, and chemotherapy proved inadequate.
Journal of the American Academy of Dermatology 12/1991; 25(5 Pt 2):925-8. · 3.99 Impact Factor
-
[show abstract]
[hide abstract]
ABSTRACT: When the scalp exhibits folds and furrows resembling gyri, it is termed cutis verticis gyrata. The possible etiologies may be categorized as primary essential, primary nonessential, and secondary cutis verticis gyrata. This is based on history, physical examination, and histologic criteria with or without laboratory examinations.
International Journal of Dermatology 11/1991; 30(10):710-2. · 1.14 Impact Factor
-
The Journal of dermatologic surgery and oncology 10/1991; 17(9):707-8, 761-2.
